Correlation Between 40434LAL9 and Avadel Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both 40434LAL9 and Avadel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 40434LAL9 and Avadel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HPQ 42 15 APR 32 and Avadel Pharmaceuticals PLC, you can compare the effects of market volatilities on 40434LAL9 and Avadel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 40434LAL9 with a short position of Avadel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 40434LAL9 and Avadel Pharmaceuticals.

Diversification Opportunities for 40434LAL9 and Avadel Pharmaceuticals

-0.12

Correlation Coefficient

40434LAL9  Avadel Pharmaceuticals

Good diversification

The 3 months correlation between 40434LAL9 and Avadel is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding HPQ 42 15 APR 32 and Avadel Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avadel Pharmaceuticals and 40434LAL9 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HPQ 42 15 APR 32 are associated (or correlated) with Avadel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avadel Pharmaceuticals has no effect on the direction of 40434LAL9 i.e., 40434LAL9 and Avadel Pharmaceuticals go up and down completely randomly.

Pair Corralation between 40434LAL9 and Avadel Pharmaceuticals

Assuming the 90 days trading horizon HPQ 42 15 APR 32 is expected to generate 0.12 times more return on investment than Avadel Pharmaceuticals. However, HPQ 42 15 APR 32 is 8.57 times less risky than Avadel Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Avadel Pharmaceuticals PLC is currently generating about -0.06 per unit of risk. If you would invest  9,376  in HPQ 42 15 APR 32 on December 25, 2024 and sell it today you would earn a total of  39.00  from holding HPQ 42 15 APR 32 or generate 0.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	96.72%
Values	Daily Returns

HPQ 42 15 APR 32  vs.  Avadel Pharmaceuticals PLC

HPQ 42 15

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in HPQ 42 15 APR 32 are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 40434LAL9 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Avadel Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with 40434LAL9 and Avadel Pharmaceuticals

The main advantage of trading using opposite 40434LAL9 and Avadel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 40434LAL9 position performs unexpectedly, Avadel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avadel Pharmaceuticals will offset losses from the drop in Avadel Pharmaceuticals' long position.

The idea behind HPQ 42 15 APR 32 and Avadel Pharmaceuticals PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.